secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cencora, Inc. (COR)
CIK:        0001140859
Form:       8-K
Filed at:   2024-08-15T23:59:59+00:00
Accession:  0001104659-24-089929
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cencora elects Frank Clyburn to its board of directors, effective Oct 1, 2024
-----------------------------------------------------------------------------

- Frank Clyburn appointed as independent director, effective October 1, 2024.
- Board will increase from 11 to 13 members as a result.
- Clyburn previously CEO of IFF and EVP at Merck; brings pharmaceutical industry expertise.
- Compensation follows non-employee director policy, pro-rated until 2025 annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1140859/000110465924089929/0001104659-24-089929-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1140859/000110465924089929/tm2421656d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-089929

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer